Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Doctor's Office, 9/F, Tower B, 1 Shing Cheong Road, Kowloon Bay, Kowloon, Hong Kong.
Department of Pharmacy, Hong Kong Children's Hospital, G/F, Tower B, 1 Shing Cheong Road, Kowloon Bay, Kowloon, Hong Kong.
J Nephrol. 2023 Jun;36(5):1425-1434. doi: 10.1007/s40620-023-01613-z. Epub 2023 Apr 15.
Acute kidney injury (AKI) is common among critically ill children and these children are at risk of developing acute kidney disease (AKD).
A prospective cohort study was conducted on children aged > 1 month to ≤ 18 years old admitted to the pediatric intensive care unit (ICU) of Hong Kong Children's Hospital from 6/2020 to 6/2021. The incidences and risk factors of both AKI and AKD were determined.
There were 254 eligible admissions (58.3% in males, with a median age of 4.9 [9.7] years). The overall AKI incidence was 41.7% and 56% of children who remained hospitalized in the pediatric ICU for ≥ 7 days after acquiring AKI developed AKD. Cardiac surgery, bone marrow transplantation and requirement of inotropes were risk factors for both AKI and AKD. The requirement of non-invasive ventilation [relative risk (RR): 2.625 (1.361, 5.064)], total medication dose [RR 1.006 (1.002, 1.010)] and maximal medication intensity [RR 1.154 (1.038, 1.283)] were additional determinants of AKI. Factors indicating more severe AKI and AKI progression were predictive of AKD development. The overall mortality in the pediatric ICU was 3.1%. AKI was significantly associated with mortality (p < 0.001), longer length of hospitalization in the pediatric ICU (p < 0.001) and hospital stay (p < 0.001). AKD was associated with a lower estimated glomerular filtration rate at discharge from the pediatric ICU (p = 0.036).
AKI and AKD were common among critically ill children, and were associated with significant morbidity and mortality. Few modifiable risk factors, especially those related to nephrotoxic medication exposure, were associated with AKI development and AKD progression.
急性肾损伤(AKI)在危重症患儿中较为常见,这些患儿存在发生急性肾疾病(AKD)的风险。
对 2020 年 6 月至 2021 年 6 月期间入住香港儿童医院儿科重症监护病房(PICU)的年龄>1 个月至≤18 岁的患儿进行前瞻性队列研究。确定 AKI 和 AKD 的发生率和危险因素。
共有 254 例符合条件的入院患儿(58.3%为男性,中位年龄为 4.9[9.7]岁)。总体 AKI 发生率为 41.7%,在获得 AKI 后仍在 PICU 住院≥7 天的患儿中,有 56%发展为 AKD。心脏手术、骨髓移植和使用正性肌力药是 AKI 和 AKD 的危险因素。需要无创通气[相对风险(RR):2.625(1.361,5.064)]、总药物剂量[RR 1.006(1.002,1.010)]和最大药物强度[RR 1.154(1.038,1.283)]是 AKI 的其他决定因素。提示 AKI 更严重和进展的因素与 AKD 的发生相关。儿科 ICU 的总体死亡率为 3.1%。AKI 与死亡率显著相关(p<0.001)、儿科 ICU 住院时间延长(p<0.001)和住院时间延长(p<0.001)。AKD 与儿科 ICU 出院时肾小球滤过率估计值降低相关(p=0.036)。
AKI 和 AKD 在危重症患儿中较为常见,与显著的发病率和死亡率相关。少数可改变的危险因素,特别是与肾毒性药物暴露相关的危险因素,与 AKI 的发生和 AKD 的进展相关。